1,733 Shares in Humana Inc. $HUM Bought by FFG Partners LLC

FFG Partners LLC bought a new stake in shares of Humana Inc. (NYSE:HUM) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 1,733 shares of the insurance provider’s stock, valued at approximately $300,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Capital International Investors increased its holdings in shares of Humana by 113.9% in the fourth quarter. Capital International Investors now owns 5,818,008 shares of the insurance provider’s stock valued at $1,490,239,000 after purchasing an additional 3,097,571 shares during the period. Norges Bank purchased a new position in Humana during the 4th quarter worth approximately $456,632,000. Wellington Management Group LLP lifted its stake in Humana by 4,481.7% during the 4th quarter. Wellington Management Group LLP now owns 1,196,502 shares of the insurance provider’s stock valued at $306,460,000 after acquiring an additional 1,170,387 shares during the period. Franklin Resources Inc. boosted its holdings in shares of Humana by 914.5% in the 4th quarter. Franklin Resources Inc. now owns 1,255,665 shares of the insurance provider’s stock valued at $321,613,000 after acquiring an additional 1,131,893 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA boosted its holdings in shares of Humana by 28.9% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 4,496,775 shares of the insurance provider’s stock valued at $1,151,759,000 after acquiring an additional 1,008,514 shares during the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Humana Price Performance

Shares of HUM stock opened at $360.78 on Tuesday. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.77 and a quick ratio of 1.77. The company has a market capitalization of $43.32 billion, a PE ratio of 38.59, a price-to-earnings-growth ratio of 2.05 and a beta of 0.76. The firm’s 50-day moving average is $289.14 and its two-hundred day moving average is $242.42. Humana Inc. has a 12 month low of $163.11 and a 12 month high of $380.86.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share for the quarter, topping the consensus estimate of $9.97 by $0.34. The company had revenue of $39.65 billion during the quarter, compared to analyst estimates of $39.37 billion. Humana had a return on equity of 10.45% and a net margin of 0.82%.The firm’s revenue for the quarter was up 23.5% compared to the same quarter last year. During the same period in the prior year, the business posted $11.58 earnings per share. Humana has set its FY 2026 guidance at 9.000- EPS. Analysts predict that Humana Inc. will post 9.04 earnings per share for the current year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date is Friday, June 26th. Humana’s dividend payout ratio (DPR) is 37.86%.

Wall Street Analyst Weigh In

HUM has been the topic of a number of recent research reports. Oppenheimer upgraded Humana from an “outperform” rating to an “outperform” rating in a research note on Wednesday, May 20th. William Blair assumed coverage on Humana in a research report on Wednesday, May 20th. They set an “outperform” rating for the company. Piper Sandler reissued a “neutral” rating and issued a $254.00 price target (up from $182.00) on shares of Humana in a report on Wednesday, May 13th. Morgan Stanley raised their price objective on shares of Humana from $217.00 to $249.00 and gave the stock an “underweight” rating in a research note on Thursday, June 4th. Finally, Jefferies Financial Group raised shares of Humana from a “buy” rating to a “buy” rating in a report on Wednesday, May 20th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, sixteen have issued a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $291.35.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.